Literature DB >> 33291248

Shear Wave Dispersion Predicts Liver Fibrosis and Adverse Outcomes in Patients with Heart Failure.

Himika Ohara1, Akiomi Yoshihisa1,2, Shinji Ishibashi3, Mitsuko Matsuda3, Yukio Yamadera3, Yukiko Sugawara1, Yasuhiro Ichijo1, Yu Hotsuki1, Koichiro Watanabe1, Fumiya Anzai1, Yu Sato1, Yusuke Kimishima1, Tetsuro Yokokawa1, Tomofumi Misaka1,2, Takamasa Sato1, Masayoshi Oikawa1, Atsushi Kobayashi1, Yasuchika Takeishi1.   

Abstract

BACKGROUND: It has been recently reported that liver stiffness assessed by transient elastography reflects right atrial pressure (RAP) and is associated with worse outcomes in patients with heart failure (HF). However, the relationship between shear wave dispersion (SWD, a novel indicator of liver viscosity) determined by abdominal ultrasonography and RAP, and the prognostic impact of SWD on HF patients have not been fully examined. We aimed to clarify the associations of SWD with parameters of liver function test (LFT) and right heart catheterization (RHC), as well as with cardiac events such as cardiac death and worsening HF, in patients with HF.
METHODS: We performed abdominal ultrasonography, LFT and RHC in HF patients (n = 195), and followed up for cardiac events. We examined associations between SWD and parameters of LFT and RHC.
RESULTS: There were significant correlations between SWD and circulating levels of direct bilirubin (R = 0.222, p = 0.002), alkaline phosphatase (R = 0.219, p = 0.002), cholinesterase (R = -0.184, p = 0.011), and 7S domain of collagen type IV (R = 0.177, p = 0.014), but not with RAP (R = 0.054, p = 0.567) or cardiac index (R = -0.015, p = 0.872). In the Kaplan-Meier analysis, cardiac event rate was significantly higher in the high SWD group (SWD ≥ 10.0 (m/s)/kHz, n = 103) than in the low SWD group (SWD < 10.0 (m/s)/kHz, n = 92; log-rank, p = 0.010). In the Cox proportional hazard analysis, high SWD was associated with high cardiac event rates (hazard ratio, 2.841; 95% confidence interval, 1.234-6.541, p = 0.014). In addition, there were no interactions between SWD and all subgroups, according to the subgroup analysis.
CONCLUSIONS: SWD assessed by abdominal ultrasonography reflects liver fibrosis rather than liver congestion, and is associated with adverse prognosis in HF patients.

Entities:  

Keywords:  abdominal ultrasonography; fibrosis; liver function test; prognosis; right heart catheterization; viscosity

Year:  2020        PMID: 33291248      PMCID: PMC7762121          DOI: 10.3390/jcm9123953

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  44 in total

1.  Liver elasticity and viscosity quantification using shearwave dispersion ultrasound vibrometry (SDUV).

Authors:  Shigao Chen; Matthew W Urban; Cristina Pislaru; Randall Kinnick; James F Greenleaf
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2009

2.  EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis.

Authors: 
Journal:  J Hepatol       Date:  2015-04-21       Impact factor: 25.083

3.  Investigating liver stiffness and viscosity for fibrosis, steatosis and activity staging using shear wave elastography.

Authors:  Thomas Deffieux; Jean-Luc Gennisson; Laurence Bousquet; Marion Corouge; Simona Cosconea; Dalila Amroun; Simona Tripon; Benoit Terris; Vincent Mallet; Philippe Sogni; Mickael Tanter; Stanislas Pol
Journal:  J Hepatol       Date:  2014-09-22       Impact factor: 25.083

4.  Liver fibrosis marker, 7S domain of collagen type IV, in patients with pre-capillary pulmonary hypertension.

Authors:  Akiomi Yoshihisa; Yusuke Kimishima; Takatoyo Kiko; Yu Sato; Shunsuke Watanabe; Yuki Kanno; Satoshi Abe; Makiko Miyata-Tatsumi; Takamasa Sato; Satoshi Suzuki; Masayoshi Oikawa; Atsushi Kobayashi; Takayoshi Yamaki; Koichi Sugimoto; Hiroyuki Kunii; Kazuhiko Nakazato; Hitoshi Suzuki; Takafumi Ishida; Yasuchika Takeishi
Journal:  Int J Cardiol       Date:  2018-02-08       Impact factor: 4.164

Review 5.  Interactions of the heart and the liver.

Authors:  Søren Møller; Mauro Bernardi
Journal:  Eur Heart J       Date:  2013-07-12       Impact factor: 29.983

6.  Viscoelasticity Measurement in Rat Livers Using Shear-Wave US Elastography.

Authors:  Katsutoshi Sugimoto; Fuminori Moriyasu; Hisashi Oshiro; Hirohito Takeuchi; Yu Yoshimasu; Yoshitaka Kasai; Yoshihiro Furuichi; Takao Itoi
Journal:  Ultrasound Med Biol       Date:  2018-06-21       Impact factor: 2.998

7.  Liver dysfunction assessed by model for end-stage liver disease excluding INR (MELD-XI) scoring system predicts adverse prognosis in heart failure.

Authors:  Satoshi Abe; Akiomi Yoshihisa; Mai Takiguchi; Takeshi Shimizu; Yuichi Nakamura; Hiroyuki Yamauchi; Shoji Iwaya; Takashi Owada; Makiko Miyata; Takamasa Sato; Satoshi Suzuki; Masayoshi Oikawa; Atsushi Kobayashi; Takayoshi Yamaki; Koichi Sugimoto; Hiroyuki Kunii; Kazuhiko Nakazato; Hitoshi Suzuki; Shu-ichi Saitoh; Yasuchika Takeishi
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

8.  What we need to know when performing and interpreting US elastography.

Authors:  So Hyun Park; So Yeon Kim; Chong Hyun Suh; Seung Soo Lee; Kyoung Won Kim; So Jung Lee; Moon-Gyu Lee
Journal:  Clin Mol Hepatol       Date:  2016-09

9.  Clinical utilization of shear wave dispersion imaging in diffuse liver disease.

Authors:  Katsutoshi Sugimoto; Fuminori Moriyasu; Hisashi Oshiro; Hirohito Takeuchi; Yu Yoshimasu; Yoshitaka Kasai; Takao Itoi
Journal:  Ultrasonography       Date:  2019-07-26

10.  Liver stiffness assessed by Fibrosis-4 index predicts mortality in patients with heart failure.

Authors:  Yu Sato; Akiomi Yoshihisa; Yuki Kanno; Shunsuke Watanabe; Tetsuro Yokokawa; Satoshi Abe; Tomofumi Misaka; Takamasa Sato; Satoshi Suzuki; Masayoshi Oikawa; Atsushi Kobayashi; Takayoshi Yamaki; Hiroyuki Kunii; Kazuhiko Nakazato; Shu-Ichi Saitoh; Yasuchika Takeishi
Journal:  Open Heart       Date:  2017-04-28
View more
  1 in total

1.  Shear wave dispersion to assess liver disease progression in Fontan-associated liver disease.

Authors:  Tomoaki Nagasawa; Hidekatsu Kuroda; Tamami Abe; Hirofumi Saiki; Yasuhiro Takikawa
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.